Abstract Details

Title Patterns of Malignant Glioma Relapse after Discontinuing Bevacizumab Prior to Disease Recurrence

Topic Neuro-oncology

Presentation(s) (-)

Poster/Presentation
Number 138

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Wendy Sherman, MD (Mayo Clinic)	Dr. Sherman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Focused ultrasound foundation . Dr. Sherman has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Kiyatec.
Jeffrey J. Raizer, MD	No disclosure on file
Sean Grimm, MD (Rush University)	Dr. Grimm has nothing to disclose.
	No disclosure on file

��ɫ����